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Abstract
The critical care involved in solid-organ transplantation (SOT) is complex. Pre-, intra- and post-transplant care can
significantly impact both – patients’ ability to undergo SOT and their peri-operative morbidity and mortality. Much
of the care necessary for medical optimization of end-stage organ failure (ESOF) patients to qualify and then successfully undergo SOT, and the management of peri-operative and/or long-term complications thereafter occurs in an intensive care unit (ICU) setting. The current literature specific to critical care in abdominal SOT patients was reviewed.
This paper provides a contemporary perspective on the potential multifactorial advantages of sub-specialized transplant critical care units in providing efficient, comprehensive, and collaborative multidisciplinary care.
Keywords: solid-organ transplantation, abdominal organ transplantation, critical care medicine
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Introduction

Knowledge and technology have transformed the practice of medicine, and both with the need to optimize
outcomes have been the driving force in creating subspecialties in virtually every realm of clinical medicine. Critical care medicine is no exception with the
consequent evolution of sub-specialized units in the
areas of pediatrics and neonatology, cardiology and
cardiac surgery, and neurology and neurosurgery [1].
Patients with end-stage organ failure (ESOF), particularly those in need of, or those who have undergone
solid-organ transplantation (SOT), represent a unique
patient population. Complexities in the management
of SOT patients pose challenges to the healthcare team
at every level. The critical care of SOT patients, both
in the pre- and post-transplant phase, is essential. It
impacts on their potential candidacy for donated organs and subsequently influences their post-transplant
morbidity, mortality, and allograft survival [2]. With
pre-transplant ESOF, an extensive, complicated surgical procedure, unique post-operative management of
*

the recipient (allograft included) and careful balance of
immunosuppression, it is imperative that critical care
rendered to the transplant patient has a multidisciplinary approach inclusive of transplant physicians and
skilled intensivists.

Challenges

in Transplant Patients
Patients with impending or established single- or multi-organ failure can be defined as critically ill. Patients
awaiting SOT and transplant recipients often drastically decompensate when complications arise. Review
articles by Findlay et al. and Razonable et al. outline
topics in critical care management of unique complications, encountered to varying degrees, in SOT patients
[3,4].

Pre-Transplant

Phase
Successful management of patients with ESOF requires
an understanding of their pathophysiology and the
complications that may ensue. It is not uncommon to

Correspondence to: Correspondents to: Sujit Vijay Sakpal, Plaza 3. 1315 S. Cliff Ave. Suite 1100. Sioux Falls. SD 57105, USA. Email: sujit.sakpal@avera.org; sujit.sakpal@usd.edu

84 • The Journal of Critical Care Medicine 2018;4(3)

encounter bouts of hepatic encephalopathy (HE) and
spontaneous bacterial peritonitis (SBP) in potential
liver recipients, or catheter-related multi-drug resistant
(MDR) sepsis with disseminated infection in patients
with end-stage renal disease (ESRD) with challenging dialysis access or those with intestinal failure dependent on parenteral nutrition. Complications such
as porto-pulmonary hypertension (PPH) and hepatopulmonary syndrome (HPS) in end-stage liver disease
(ESLD) patients compromise cardiovascular physiology, ventricular function and respiratory mechanics
which may threaten transplantation [5]. Renal failure,
acute or chronic, in ESLD patients necessitates early
recognition, differentiation from hepatorenal syndrome (HRS), and timely treatment that may involve
renal replacement therapy (RRT). In wait-listed ESLD
patients, progressive deterioration of renal function or
prolonged RRT demands periodic re-evaluation for
multi-organ transplantation. While complications, as
mentioned above, dictate patients’ survival, they pose
a constant threat to their transplant eligibility and may
jeopardize their candidacy for life-saving organ offers.
Thus, it is essential that one understands the pursuit of
aggressive therapy in these patients to enable them to
receive SOT and thereby heal.
In addition to treating complications, pre-transplant
medical optimization of ESOF patients is a vital task.
A concerted, multidisciplinary approach is key to
maintaining a patient’s eligibility for transplantation.
For example, orchestrating collaborative therapeutic
strategies with neurocritical care intensivists and nephrologists with regards to volume status, and hepatologists and infectious disease (ID) specialists, is critical
for preventing a fatal outcome from elevated intracranial pressure (ICP) in patients with acute liver failure
(ALF) [6,7]. Similarly, patients suffering from PPH and
HPS require dedicated pharmacological therapy with
the keen management of fluid-volume status in accord
with a pulmonologist.

Post-Transplant

Phase
Cardiovascular disease and related events are the leading cause of morbidity, graft loss, and mortality in
kidney transplant recipients [8]. Optimizing recipient physiology following SOT yields the most significant chance of allograft function and overall survival.
A multivariable balancing act inclusive of continuous
fluid-volume status adjustments, customized antico-
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agulation if and when necessary, and maintenance of
adequate tissue perfusion is vital in the restoration of
physiological homeostasis and prevention of allograft
thrombosis. At the time of obtaining consent before
transplantation, patients are informed of the “big operation, big incision, big pain, big recovery, and possible
big complications.” More often than expected, transplant recipients encounter various acute or chronic
complications.
A multitude of different bacterial, viral and fungal
infections may plague transplant recipients requiring
aggressive testing methods and alternative therapeutic
strategies. Immediately post-transplant, recipients may
suffer from wound infection, C. difficile colitis, urinary
tract infection (UTI), or ventilator-associated events
(VAEs) from prolonged mechanical ventilation. Bile
leak(s) or anastomotic ductal stenosis may progress
to cholangitis, bacteremia, sepsis and shock in liver
recipients. Alike, urinoma(s) and ureteral stricture(s)
may develop infectious complications in kidney recipients. Furthermore, a variety of opportunistic and late
post-transplant infections may cause transplant recipients to be admitted to the intensive care unit (ICU).
Frequently, transplant recipients (including kidney)
sustain acute kidney injury (AKI) and may even require RRT. This may exacerbate cardiorespiratory insufficiency or failure especially in recipients with preexisting pulmonary complications of cirrhosis or those
with suboptimal cardiac or ventricular function. That
said, very often we witness liver transplantation to be
the therapy, cause for the cure of HRS, HPS, PPH, cerebral edema, hyperdynamic circulation, multifactorial
coagulopathy, and Kwashiorkor malnutrition [9]. Such
remarkable transformations are mainly limited to the
field of SOT.
The incidence and severity of post-transplant complications are remarkably high in intestinal transplant
(IT) recipients. In this group of SOT recipients — micronutrient deficiencies commonly occur due to the
gradual allograft adaptation. Acute and/or chronic allograft rejection may manifest with increased stomal
output and consequent AKI, and sepsis secondary to
bacterial translocation [10,11]; and graft-versus-host
disease (GVHD) has an incidence of 7% due to the
presence of a robust intestinal lymphatic system which
may present with hepatic dysfunction and bone marrow depression [12].
A widening gap between the supply of allografts
appropriate for transplantation and the continu-
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ous increase in demand concerning patients awaiting
transplant has prompted aggressive donor utilization.
Simultaneously, increasingly moribund and decompensated recipients are undergoing transplantation.
Thus, early identification and appropriate management of poorly functioning grafts have become a critical aspect of post-transplant care [4,13]. Hepatic artery
(HAT) or portal venous thrombosis (PVT), and venous
outflow or biliary obstruction requires timely recognition and therapy to save or improve liver allograft function. Similarly, any suspected vascular compromise following renal or pancreatic transplantation necessitates
swift diagnosis and treatment. Also, modifying, tailoring and balancing immunosuppressive regimen in SOT
recipients has a pivotal role in combating complications
inclusive of rejection or infection.

Is
 there a need for Transplant Critical Care?
In 2012, of the total 5,731 adult liver transplants performed in the United States, 17.9% (1,028) occurred
in recipients with a Model for End-stage Liver Disease (MELD) score >35 [14]. Before transplantation,
723 (12.6%) recipients were hospitalized in the ICU
of which 403 (7%) had been on life support, and 192
(3.4%) were listed as status 1. Early post-transplant tracheal extubation is safe and suggests efficient resource
use without significant reduction in ICU or hospital
length of stay (LOS) in selected liver transplant patients
[15,16]. However, despite attempts to fast-track care
and avoid an ICU stay, 45.7% of orthotropic liver transplant (OLT) patients require immediate ICU stay [17].
Infrequent compared to liver, 6.6% (452/6,819) of
kidney transplant patients demonstrated the need for
ICU admission in a study by Canet et al. [18]. Fortyfour percent (200) of these patients were admitted for
acute respiratory failure from bacterial pneumonia
(35.5%), cardiogenic pulmonary edema (24.5%) and
extrapulmonary acute respiratory distress syndrome
(ARDS) (15.5%); and almost half of these patients
required either, or a combination thereof, mechanical ventilation, vasopressors, and RRT. Other studies
have shown that up to 20% of renal transplant recipients require escalation of care from the ward to ICU
and higher mortality among kidney recipients requiring ICU than the general ICU population (42.6% vs
30%) [19,20]. Only 1.4% of renal transplant recipients
are readmitted to the ICU but up to 35% of first time
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successful OLTs return to the ICU primarily for infectious or septic complications (51%), cardiopulmonary
dysfunction (35%) and graft failure (22%) [21]. Most
infrequent of the abdominal SOTs, data from 165 ITs
performed at a single center revealed a mean duration
of 16+/- 23 ICU days post-transplantation [10]. These
aforementioned figures underestimate the actual use of
the ICU by SOT patients because it does not include
those who get admitted to the ICU with an acute illness
but recover, those who die in the ICU without having
their status upgraded, or those who get admitted to the
ICU for a condition that results in their removal from
the transplant wait-list [9]. With an increasing number
of transplant candidates on the list and their extended
length of time awaiting organs, increasing number of
patients requiring ICU care before transplantation can
be anticipated.
Thus, inception of sub-specialized transplant critical care units at moderate-to-high-volume centers have
the potential to have a multifold impact - the welfare
of individual patient(s) and allograft(s), development
of the multi-organ transplant program, and further the
understanding of modern surgical critical care of complex SOT patients.

Patients

First, and The Allograft
Too!
Specialized care is an absolute necessity to combat
complexities that may occur in transplant candidates
and recipients. In fact, candidacy for life-saving organs
relies heavily on the critical management of extremely
sick patients awaiting transplants. For patients who are
not transplant candidates, the goal is the restoration of
pre-ICU functional status, recognizing that ESOF is an
incurable condition without transplantation [22]. For
listed transplant patients, the goal is to provide a “window” of clinical stability when transplantation could be
feasible. For patients who are possible transplant candidates, the goal is to provide a “window” of opportunity
to complete a candidacy work-up. The key challenge is
keeping this “window” open because recurrence of illness after resolution of the initial episode is common.
Striving to achieve these “windows” of opportunity
must be counterbalanced against potentially futile care
and provision of false hope. In critically ill ESOF patients, deemed as transplant candidates, the following
series of events must take place to achieve a good outcome:
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•
•
•
•

resolution of acute illness,
non-recurrence of another illness,
completion of candidacy work-up, and
a successful transplant operation at the availability of suitable organ(s).
Provision of post-operative care is a fundamentally
shared responsibility of the multidisciplinary care team
including subspecialty physicians, intensivists, and
transplant surgeons who understand complex anatomy
as well as the impact of the procedures they perform
on the individual patient’s physiology [2]. Post-operative allograft function or dysfunction reflects the interplay of donor factors, the recipient’s acuity and the
recipient’s operative course [1]. It is not just monitoring of graft function that is vital, but early suspicion
and recognition of graft dysfunction is critical. While
implantable continuous Dopplers are being used for
prompt detection of HAT post-liver transplantation,
such devices still do not substitute the medical judgement and experience of skilled transplant surgeons in
conjunction with critical care-trained physicians [10].
More importantly, rapid assessment of the recipient
must be followed up with, if necessary, escalated care
and definitive therapeutics implemented expeditiously
sometimes to save an allograft. For example, elevated
liver function tests (LFTs) post-OLT should prompt
acquisition and interpretation of liver Doppler images
with immediate angiographic or operative intervention
as necessary.
Acute and chronic pathophysiologic changes associated with SOT can cause substantial emotional distress and psychological stresses among this subset of
patients. These stresses are accentuated in the ICU setting which could influence immediate and long-term
outcomes of SOT. Thus, in addition to their medical
needs, it is essential to recognize and address the psychological and psychiatric needs of these patients [23].

Volume

Expansion, Quality Improvement & Resource Utilization
Volume expansion continues to be the biggest challenge in the field of SOT. Despite significant scientific
advancements in the process of SOT over the past five
decades, the stagnant supply of quality organs has been
unable to match the ongoing demand of allografts.
In the United States, approximately only a quarter of
the current wait-listed candidates for all organ types
(114,561) have been transplanted annually over the
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past decade (27,764 - 34,772) [24]. Thus, to sustain or
better outcomes one has to think outside the box.
Three decades ago, up to 40% of all deaths in liver
transplant recipients occurred in the ICU, mostly from
infectious causes [25]. Comprehensive understanding
of SOT physiology and pathophysiology, and advancements in medicine - antibiosis, immunosuppression,
diagnostic-therapeutic modalities in critical care - have
effectively reduced the mortality among critically ill
OLT recipients below the overall mortality rate for all
ICU admissions (10.6% versus 15%) [21]. Effective
critical care supports a transplant program’s ability to
consider high-risk donors and high-risk recipients,
which expectantly would enhance the overall survival
of the population of patients with ESOF [1,26]. This is
where assurance of skillful, experienced, transplantspecific and critical care competent peri-operative
management is essential to be able to:
• venture with suboptimal organ offers,
• cater to complex patients with multiple co-morbidities or high “MELDers”, and
• produce consistent and improved results.
Hospitals incur substantial costs due to repetitive,
redundant and frequently unnecessary physician consultations and diagnostic tests. Also, soaring healthcare
costs cannot be neglected by the current state of affairs. Care rendered to patients post-transplant (or pretransplant) determines their morbidity, mortality and
largely dictates outcomes, which is perceived as quality.
Thus, emphasis must be on providing consistent, efficient and high-quality care to patients primarily in a
high-volume setting to produce and sustain superior
outcomes.
Undeniably, multidisciplinary care is central to the
management of SOT patients. Invaluable input from
experienced specialists in critical care, hepatology, nephrology, anesthesiology, ID, hematology, and pulmonology is essential for the successful care of SOT patients. Patients’ intensive care team also includes, and is
not limited to, specialized transplant nurses, advanced
practice providers (APPs), pharmacists, psychologists,
respiratory-physical-occupational therapists (RT, PT,
OT), and social workers or case managers. Self-learning
and continually educating team members is vital. Additionally, astute utilization of available resources and
timely, relevant assistance from interdisciplinary colleagues should be the strategy for practical outcomes.
Allotment of physical space with dedicated resources
solely for a SOT program is a considerable task. Its fea-
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sibility depends on multiple factors including administrative and financial support based on an institution’s
individualized funding capabilities, and the influx of
ESOF patients referred for SOT evaluation. While it
may be economically justifiable to “concentrate” space
and resources in establishing a transplant-only ICU
at high volume multi-organ SOT centers, the concept
may prove to be inefficient and unjustified with regards
to apt utilization of resources at low-to-moderate volume SOT centers. Differently, allocation of designated
beds within an institution’s existing ICUs (for example,
5 to 8 beds in a 24-bed medical or surgical ICU) with
an option to “overflow” may be an equally competent
alternative. Note, that we emphatically stress the value
of leading a collaborative, multidisciplinary program
which includes the aforementioned transplant-specialized clinicians and all members of the intensive care
team. Regardless of the actual existence of a transplantonly ICU, an ambitious transplant leadership must
strive to cultivate an intensive care team equipped with
the “transplant ways” essential to efficiently manage
ESOF patients, simultaneously and expeditiously enable assessment of patients’ candidacy for SOT, and
treat patients, either peri-operatively or those with
long-term complications, following SOT.
While some ESOF patients do not qualify to become
transplant candidates, some transplant recipients suffer
and succumb to irreversible graft failure or fatal complications. For these patients, responsibly determining
futility of care can be a challenge, yet it is essential to
maintain communication within the multidisciplinary
care team and with patients or their families to achieve
early consensus on goals of care for dying transplant
patients. Timely integration of palliative care alongside
an aggressive, disease-focused, curative care must be
accomplished in the ICU to improve the end-of-life
care practice for patients in whom prolonging treatment is deemed futile [27]. Also, transfer of the terminally ill transplant patient to the ICU must be refrained
to avoid the unnecessary utilization of resources, the
provision of false hopes and expectations, and the indignities that occur when suffering and death take
place in an inappropriate environment [9].
Hence, collaborative efforts between the transplant
and ICU physicians and teams are essential to the management of the SOT patient. Creating a workforce of
clinicians who have training in both specialties may
help to synergize the care required for this complex patient population.
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Model

Creation, Innovation
The field of SOT has matured significantly over the last
two decades. Rather than being complacent of the accomplishments and accept the status quo, this is the
time to build, expand and innovate. Advancements
in operative techniques and developments in immunosuppressive therapy have paved the way to perform
more complex surgical procedures under challenging
clinical scenarios. Hence, continually identifying areas
in need of improvement is essential, and critical transplant care is one such area.
Design and establishment of a goal-directed, dedicated, sub-specialized ICU to cater to the critical needs
of ESOF patients, either in need of an allograft or those
who have received one (or more), will provide an opportunity to explore novel models in SOT patient care.
Creation of a prospective database of critically ill transplant candidates and recipients will allow us to:
• expand understanding of complex pathologies in
this unique class of patients,
• assess and improvise day-to-day performance,
and
• modify current protocols and design new ones
based on evolving evidence.
Such design-thinking makes for a robust approach,
in combination with creativity, to perform a needsfinding exercise which can identify unmet needs and
explore areas of opportunity.
It could be argued that surgeons without formal
critical care training may not be ideal or rather wellequipped for managing complicated ventilator settings
or pressors-ionotropes in hemodynamically labile patients. However, most abdominal transplant surgeons
and in-training fellows receive a concentrated experience in the care of SOT patients including their ICU
care [2]. That said, this may be an impetus for abdominal SOT fellowship training programs to expand their
curriculum involving intensive care. For example,
“routine” ICU procedures such as endotracheal intubation, advanced ventilator management, fiber optic bronchoscopy and point-of-care-ultrasonography
(POCUS) should be considered for mandatory inclusions. As surgical training continues to evolve, the inclusion of an intensive-care specific curriculum in addition to the technical training that SOT fellows receive
may provide a workforce that can straddle the worlds
of transplant and intensive care. In addition, including
a transplant-specific rotation during an intensive care
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fellowship - focusing on the needs of the SOT patient
without learning the technical aspects - may assist with
developing the workforce that is necessary for developing a transplant-specific intensive care model.

Conclusion

Incorporation of sub-specialized critical care units in
the management of transplant patients has the potential to have a global impact. Under a transplant and intensive care physician collaborative leadership model
synchronized, multidisciplinary and aggressive efforts
are paramount to:
• maximize SOT in qualified potential recipients,
and
• successfully combat probable complications and
improve overall outcomes in allograft recipients.
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